Delivery Order SPE2DB22D3501-SPE2DB25FVD72

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,728.16 Firm Fixed Price Delivery Order is for the supply of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of REMICADE 100 MG VIALS to the Defense Logistics Agency (DLA). The $8,408.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $12,745.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Remicade 100 mg vials, a pharmaceutical product, with a completion date of April 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The award is not associated with any set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,275.20 firm fixed-price delivery order is for the supply of REMICADE 100 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,024.40, is for the supply of 4,568,093,049 units of Remicade 100 mg vials. The award has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Remicade 100 mg vials. The contract has a ceiling value of $17,943.98 and runs through October 15, 2024. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's costs. AmerisourceBergen has multiple federal contracts, including an Indefinite Delivery Contract...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,012.20, is for the delivery of REMICADE 100 MG VIALS medical supplies. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the pharmaceutical product Remicade 100 mg vials, with a ceiling value of $10,275.20 and a performance period through April 4, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUG84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,591.10 firm fixed-price delivery order contract is for the supply of 4567038437 REMICADE 100 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Remicade 100 mg vials to Conshohocken, PA. The $2,503.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVD72
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,518.30, is for the delivery of Remicade 100 mg vials. It is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/3/25, 3:05 PM